Published in J Clin Pathol on June 01, 2001
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol (2009) 1.61
My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol (2006) 1.22
Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice. Menopause (2010) 0.91
Regeneration of uterine horns in rats using collagen scaffolds loaded with human embryonic stem cell-derived endometrium-like cells. Tissue Eng Part A (2014) 0.79
Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice. Am J Pathol (2010) 0.79
Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med (1975) 5.33
Association of exogenous estrogen and endometrial carcinoma. N Engl J Med (1975) 3.89
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer (1985) 3.50
Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst (1997) 2.92
Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol (1995) 2.30
Increasing incidence of endometrial cancer in the United States. N Engl J Med (1976) 2.14
Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol (1991) 2.00
Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J (1980) 1.99
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. Am J Obstet Gynecol (1994) 1.71
Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. Int J Cancer (1996) 1.66
Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat (1999) 1.57
Histological sampling of the endometrium--a comparison between formal curettage and the Pipelle sampler. Br J Obstet Gynaecol (1992) 1.54
The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol (1957) 1.52
Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol (2000) 1.52
Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet (1997) 1.51
Outpatient pipelle endometrial biopsy in the investigation of postmenopausal bleeding. Br J Obstet Gynaecol (1994) 1.49
Combined continuous hormone replacement therapy: a critical review. Obstet Gynecol (1995) 1.46
Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol (2000) 1.44
Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol (1979) 1.39
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ (1989) 1.39
The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol (1989) 1.26
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group. Obstet Gynecol (1998) 1.25
Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand (1999) 1.14
Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med (1985) 1.10
Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study. Br J Cancer (1989) 1.09
Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium. N Engl J Med (1980) 1.05
Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol (1988) 1.03
Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy. J R Soc Med (1979) 1.01
Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet (1991) 0.96
Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). Am J Obstet Gynecol (1997) 0.96
Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol (1991) 0.93
Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol (1989) 0.93
Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women. Obstet Gynecol (1991) 0.91
The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. BJOG (2000) 0.91
Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group. Obstet Gynecol (1993) 0.88
The role and use of progestogens. Obstet Gynecol (1990) 0.86
Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. Maturitas (1982) 0.85
Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies. Am J Obstet Gynecol (1990) 0.85
A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens. N Engl J Med (1986) 0.85
Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy. Postgrad Med J (1978) 0.85
A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium. Obstet Gynecol (1989) 0.84
Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. Maturitas (1999) 0.84
Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient. Am J Obstet Gynecol (1990) 0.83
Risk of endometrial cancer in relation to use of low-dose, unopposed estrogens. Obstet Gynecol (1998) 0.82
Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes. Fertil Steril (1993) 0.82
Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Obstet Gynecol (1994) 0.82
Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy. J Am Assoc Gynecol Laparosc (1996) 0.81
A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment. Maturitas (1993) 0.81
Granulosatheca cell tumors and endometrial carcinoma; a study of their relationship and a survey of 80 cases. Obstet Gynecol (1955) 0.81
Endometrial status in post-menopausal women on long-term continuous combined hormone replacement therapy (Kliofem). A comparative study of endometrial biopsy, outpatient hysteroscopy and transvaginal ultrasound. Eur J Obstet Gynecol Reprod Biol (1997) 0.80
17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. Maturitas (1996) 0.80
The endometrial status of women on long-term continuous combined hormone replacement therapy. Br J Obstet Gynaecol (1991) 0.79
Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology. Int J Gynecol Pathol (1999) 0.79
On menstrual bleeding with hormone replacement therapy. Lancet (1994) 0.79
Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas (1981) 0.79
Oestrogen replacement treatment and the risk of endometrial cancer: an assessment of the role of covariates. Eur J Cancer (1993) 0.78
Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy. Gynecol Oncol (1994) 0.78
Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer. Gynecol Oncol (1997) 0.78
Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest. Acta Obstet Gynecol Scand Suppl (1985) 0.78
Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy. Maturitas (2000) 0.77
Endometrial responses to hormone replacement therapy: histological features compared with those of late luteal phase endometrium. Hum Reprod (1998) 0.77
Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis. Am J Obstet Gynecol (1992) 0.77
Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases. Am J Epidemiol (1981) 0.77
Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women. Maturitas (1996) 0.76
Women's opinion on withdrawal bleeding with hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol (1993) 0.76
Accumulated knowledge of Kliogest safety aspects. Br J Obstet Gynaecol (1996) 0.75
The Alder Hey affair: implications for pathology practice. J Clin Pathol (2001) 3.38
Pediatric facial fractures: evolving patterns of treatment. J Oral Maxillofac Surg (1993) 2.46
Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med (1999) 2.27
Patient selection for hysteroscopic endometrial resection. Br J Obstet Gynaecol (1991) 2.17
ACP Broadsheet No 138: May 1993. Gross examination of uterine specimens. J Clin Pathol (1993) 2.08
Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy. Histopathology (2001) 2.06
A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol (1999) 2.03
Precursor lesions of ovarian epithelial malignancy. Histopathology (2001) 2.00
Current views on cervical intraepithelial neoplasia. J Clin Pathol (1991) 1.72
DNA fingerprinting Dolly. Nature (1998) 1.69
Can HPV typing predict the behaviour of cervical epithelial neoplasia? Histopathology (1997) 1.64
Sensitive in situ hybridisation technique using biotin-streptavidin-polyalkaline phosphatase complex. J Clin Pathol (1987) 1.56
Establishment of behavioral parameters for the evaluation of osteopathic treatment principles in a rat model of arthritis. J Am Osteopath Assoc (1997) 1.41
Lessons learnt from the reorganization of maternity services. Br J Hosp Med (Lond) (2008) 1.40
Letting grief out of the closet. RN (1991) 1.37
Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry. Histopathology (2003) 1.28
Demonstration of human papillomavirus types in paraffin processed tissue from human ano-genital lesions by in-situ DNA hybridisation. J Pathol (1987) 1.21
A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry (2009) 1.19
cDNA cloning and pattern of expression of an adult, female-specific chymotrypsin from Aedes aegypti midgut. Insect Biochem Mol Biol (1997) 1.18
Intestinal adaptation and experimental carcinogenesis after partial colectomy. Increased tumour yields are confined to the anastomosis. Gut (1982) 1.16
Demonstration of multiple HPV types in normal cervix and in cervical squamous cell carcinoma using the polymerase chain reaction on paraffin wax embedded material. J Clin Pathol (1990) 1.16
Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol (1998) 1.15
p53 protein expression in putative precursor lesions of epithelial ovarian cancer. Histopathology (1995) 1.14
Autopsy: a further suggestion for its revival. N Engl J Med (1982) 1.13
Glandular lesions of the uterine cervix: the present state of our knowledge. Histopathology (1986) 1.13
Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi. Clin Exp Immunol (1984) 1.13
Circular dichroism of polypeptides. Poly(hydroxyethyl-L-glutamine) compared to poly(L-glutamic acid). J Am Chem Soc (1968) 1.09
Conformational studies on copolymers of hydroxypropyl-L-glutamine and L-leucine. Circular dichroism studies. Biochemistry (1972) 1.09
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons. J Infect Dis (1997) 1.08
In situ hybridization technique using an immunogold silver staining system. Histochem J (1989) 1.08
Perception of airway obstruction in asthma: sequential daily analyses of symptoms, peak expiratory flow rate, and mood. J Allergy Clin Immunol (1997) 1.06
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Hum Reprod (2005) 1.05
DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncol (2008) 1.05
Enteric tumours of the lower female genital tract: a report of three cases. Histopathology (1988) 1.05
Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia. J Gen Virol (2000) 1.04
Reducing distress in cancer patients with an orientation program. Psychooncology (1998) 0.99
Immune control of herpes simplex virus infections. Cancer Res (1974) 0.98
Coexistent immature teratoma of the uterus and endometrial adenocarcinoma complicated by gliomatosis peritonei. Gynecol Oncol (1985) 0.97
The pathology of meconium ileus equivalent. J Clin Pathol (1983) 0.97
Adaptation to jejunoileal bypass promotes experimental colorectal carcinogenesis. Br J Surg (1984) 0.97
Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol (1986) 0.97
Antibiotic prophylaxis in ventricular shunt surgery. I. Reduction of operative infection rates with methicillin. Childs Brain (1980) 0.96
Detection of HIV-1 infection with a green fluorescent protein reporter system. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.96
Familial malignant retroperitoneal paraganglioma. Postgrad Med J (1989) 0.95
Demonstration of human papillomavirus types 6 and 11 in juvenile laryngeal papillomatosis by in-situ DNA hybridization. J Pathol (1987) 0.94
Helminth levels of working donkeys kept under different management systems in the Moretele 1 district of the North-West Province, South Africa. Vet Parasitol (1998) 0.93
Ovarian metastasis from thyroid carcinoma 12 years after partial thyroidectomy mimicking struma ovarii: report of a case. Int J Gynecol Pathol (1994) 0.92
Flash labelling of S-phase cells in short-term organ culture of normal and pathological human endometrium using bromodeoxyuridine and tritiated thymidine. J Pathol (1988) 0.92
NHSnet-learning from academia. BMJ (1999) 0.92
Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium. Histopathology (1998) 0.91
Cytoplasmic reactivity with the monoclonal antibody HMFG1 as a marker of cervical glandular atypia. J Pathol (1987) 0.91
Some observations on liver cell proliferation in the isolated perfused rat liver. Br J Exp Pathol (1974) 0.91
The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. BJOG (2000) 0.91
Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer. Br J Cancer (2012) 0.91
Subinvolution of the uteroplacental arteries in the human placental bed. Histopathology (1989) 0.90
Primary endometrioid adenocarcinoma of the large intestine arising in colorectal endometriosis. Histopathology (2002) 0.90
Measurement of the S-phase duration in normal and abnormal human endometrium by in vitro double labelling with bromodeoxyuridine and tritiated thymidine. J Pathol (1989) 0.90
Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. Int J Gynecol Pathol (1991) 0.90
Diagnosis of molar pregnancy and persistent trophoblastic disease by flow cytometry. J Clin Pathol (1987) 0.90
Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. J Pathol (1998) 0.89
Essential fatty acid deficiency in human adults during total parenteral nutrition. Ann Intern Med (1975) 0.89
Audit of acute appendicitis in a black South African population. S Afr J Surg (1997) 0.88
Immunolocalization of alpha-amylase in ovarian mucinous tumours. Int J Gynecol Pathol (1990) 0.88
Mucin histochemistry of cystitis glandularis and primary adenocarcinoma of the urinary bladder. Arch Pathol Lab Med (1985) 0.88
Juvenile and adult laryngeal papillomata: classification by in-situ hybridization for human papillomavirus. Clin Otolaryngol Allied Sci (1989) 0.87
Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activity. Clin Cancer Res (2000) 0.87
Primary treatment of endometrial cancer with progestagen alone. Lancet (1985) 0.87
Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue. J Clin Pathol (1990) 0.87
An analysis of serum samples positive for HTLV-III antibodies. N Engl J Med (1985) 0.86
Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary. J Pathol (1997) 0.86
Production and localization of activins and activin type IIA and IIB receptors by the human endosalpinx. Reproduction (2004) 0.86
Obesity and lifestyle advice in colorectal cancer survivors - how well are clinicians prepared? Colorectal Dis (2013) 0.86
Effect of ethanol on polyamine synthesis during liver regeneration in rats. J Clin Invest (1990) 0.85
Histochemical study of endocervical glycoproteins throughout the normal menstrual cycle and adjacent to cervical intraepithelial neoplasia. Int J Gynecol Pathol (1985) 0.85
Halothane-induced changes in acetylcholine receptor channel kinetics are attenuated by cholesterol. Biochim Biophys Acta (1986) 0.85
Low molecular weight cytokeratin proteins in cervical neoplasia. J Pathol (1986) 0.85
Human papillomaviruses, p53, and cervical neoplasia. J Pathol (1994) 0.84
The effect of phytoestrogens on the female genital tract. J Clin Pathol (2002) 0.84
Direct sequencing of the p53 gene shows absence of mutations in endometrioid endometrial adenocarcinomas expressing p53 protein. Histopathology (1998) 0.83
Ovarian cysts in pregnancy: does ultrasound make traditional management inappropriate? Obstet Gynecol (1987) 0.83
Markers of endometrial function in women with unexplained recurrent pregnancy loss: a comparison between morphologically normal and retarded endometrium. Hum Reprod (2004) 0.83
Further studies of lectin binding by villous and extravillous trophoblast in normal and pathological pregnancy. Int J Gynecol Pathol (1991) 0.82
The DNA-binding domain of nuclear factor I is sufficient to cooperate with the adenovirus type 2 DNA-binding protein in viral DNA replication. J Gen Virol (1991) 0.82
Expression of epidermal growth factor receptor and transferrin receptor by human trophoblast populations. Am J Reprod Immunol (1990) 0.82
A UK consensus on the management of the bladder in multiple sclerosis. Postgrad Med J (2009) 0.82
Needle biopsy under computerized tomographic control: a method for tissue diagnosis in intracranial lesions. Neurosurgery (1979) 0.82
'Children are exposed to temptation all the time'- parents' lifestyle-related discussions in focus groups. Acta Paediatr (2011) 0.82
The distribution of beta-adrenoceptors in human cervix. Q J Exp Physiol (1989) 0.82
Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer. Cancer Res (1999) 0.81
The expression of major histocompatibility complex antigens by trophoblast in ectopic tubal pregnancy. J Reprod Immunol (1985) 0.81
Squamous cell carcinoma of the middle ear. Clin Otolaryngol Allied Sci (1980) 0.81
Peroxidase-labelled lectin binding of human extravillous trophoblast. Placenta (1987) 0.81
Laryngeal papillomatosis: correlation between severity of disease and presence of HPV 6 and 11 detected by in situ DNA hybridisation. J Clin Pathol (1989) 0.81
Overexpression of H-Ryk in epithelial ovarian cancer: prognostic significance of receptor expression. Clin Cancer Res (2000) 0.81
The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. BJOG (2003) 0.80
Immunohistochemical characterisation of trophoblast antigens and secretory products in ectopic tubal pregnancy. Int J Gynecol Pathol (1986) 0.80
Recent advances in the pathology of the vulva. Histopathology (2003) 0.80
Low-grade transitional cell carcinoma of the vagina--an unusual cause of vaginal bleeding. Histopathology (1994) 0.80